Changjiang Pharmaceutical Group Co., Ltd.

    Changjiang Pharmaceutical Group Co., Ltd.

    SSZSE:300391
    0.19
    CNY
    0.00
    (0.00%)
    Changjiang Pharmaceutical Group Co., Ltd.
    SZSE:300391
    (Shenzhen Stock Exchange)

    Recent

    price

    0.19

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CNY
    9.5
    0.95
    1.19
    1.2
    1.36
    1.02
    0.76
    1.11
    2.64
    3.82
    2.07
    3.47
    6.74
    4.61
    3.42
    0.32
    0.31
    Revenue per Share
    1.32
    0.17
    0.2
    0.19
    0.19
    0.12
    0.02
    0.02
    0.25
    0.44
    -1.91
    0.07
    0.14
    -0.07
    -1.73
    -1.79
    -1.69
    Basic EPS, GAAP
    -0.06
    -0.01
    -0.01
    -0.08
    -0.2
    -0.3
    0.07
    -0.15
    0.12
    0.56
    0.05
    0.04
    0.25
    -0.34
    -0.44
    -0.23
    - -
    Free Cash Flow per Basic Share
    0.59
    0.07
    0.1
    0.1
    0.12
    0.07
    0.1
    0.07
    0.05
    0.09
    0.08
    0.04
    0.11
    0.16
    0.18
    0.1
    0.06
    Dividend per Share
    4.61
    0.37
    0.49
    0.63
    0.74
    0.76
    1.1
    1.31
    1.34
    2.2
    -0.16
    -0.09
    0.05
    -0.02
    -1.75
    -3.54
    -3.87
    Book Value per Share
    4.73
    0.57
    0.72
    0.87
    0.93
    1.37
    1.29
    1.52
    0.96
    3.37
    1.96
    1.93
    2.41
    2.7
    1.95
    -1.47
    -1.87
    Tangible Book Value per Share
    13
    186
    188
    187
    187
    239
    251
    211
    282
    231
    350
    350
    350
    351
    350
    350
    350
    Basic Weighted Avg Shares
    128
    178
    223
    225
    255
    243
    191
    235
    744
    881
    725
    1,215
    2,362
    1,615
    1,198
    112
    109
    Sales/Revenue/Turnover
    16.91
    18.61
    19.19
    19.71
    18.51
    15.92
    -0.36
    -1.12
    11.78
    14.94
    -5.51
    7.65
    12.8
    11.39
    6.61
    -118.69
    -126.81
    Operating Margin (%)
    9
    10
    12
    14
    14
    15
    20
    26
    38
    43
    43
    43
    60
    115
    46
    37
    - -
    Depreciation Expense
    18
    31
    37
    35
    35
    29
    5
    4
    70
    102
    -670
    25
    49
    -23
    -606
    -628
    -592
    Net Income, GAAP
    7.67
    10.31
    12.49
    10.81
    10.34
    7.66
    - -
    - -
    2.62
    14.5
    - -
    - -
    - -
    37.94
    - -
    - -
    - -
    Effective Tax Rate (%)
    13.87
    17.35
    16.64
    15.75
    13.69
    11.8
    2.63
    1.8
    9.37
    11.58
    -92.33
    2.08
    2.08
    -1.44
    -50.57
    -562.56
    -545.15
    Profit Margin (%)
    -12
    46
    104
    81
    -14
    62
    87
    67
    -68
    417
    350
    -510
    -51
    197
    248
    -795
    -1,009
    Working Capital
    - -
    40
    83
    40
    20
    - -
    75
    50
    25
    - -
    - -
    345
    332
    341
    524
    446
    376
    LT Debt
    71
    117
    145
    173
    198
    365
    364
    363
    934
    1,432
    752
    1,449
    1,609
    1,665
    1,017
    -421
    -563
    Total Equity
    - -
    14.26
    14.76
    13
    11.13
    7.15
    - -
    - -
    9.29
    7.73
    - -
    - -
    - -
    4.57
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    21.02
    23.35
    18.4
    14.47
    11.78
    - -
    - -
    14.05
    16.56
    - -
    - -
    - -
    -3.25
    - -
    - -
    - -
    Return on Capital (%)
    - -
    46.84
    45.73
    33.66
    27.19
    17.89
    2.19
    1.52
    21.34
    23.08
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    304
    304
    265
    LT Borrowings
    444
    444
    375
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    350
    350
    350
    Market Capitalization
    1,766
    1,927
    1,541

    Working Capital

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    1,129
    1,185
    1,150
    Cash, Cash Equivalents & STI
    8
    9
    10
    Accounts Receivable, Net
    980
    1,023
    991
    Inventories
    42
    47
    56
    Total Current Liabilities
    1,925
    2,045
    2,160
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    304
    304
    265
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.96%
    -14.62%
    -141.42%
    Free Cash Flow
    -17.21%
    53.33%
    -48.44%
    Net Income, GAAP
    309.15%
    469.76%
    3.68%
    Sales/Revenue/Turnover
    23.27%
    2.76%
    -90.68%
    Total Cash Common Dividend
    23.4%
    31.14%
    -41.61%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    137
    339
    546
    176
    1,198
    2024
    59
    15
    27
    11
    112
    2025
    46
    25
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.07
    - -
    - -
    - -
    -1.73
    2024
    -0.14
    - -
    - -
    - -
    -1.79
    2025
    -0.17
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.03
    - -
    - -
    - -
    0.18
    2024
    0.03
    - -
    - -
    - -
    0.1
    2025
    0.01
    - -
    - -
    - -
    - -
    Similar Companies
    Business